Skip to main content
Clinical Trials/ITMCTR2000003444
ITMCTR2000003444
Recruiting
未知

Evaluation research of rehabilitation outcome of traditional Chinese medicine on stroke

The Affiliated People's Hospital of Fujian University of Traditional Chinese Medicine0 sitesTBD
ConditionsStroke

Overview

Phase
未知
Intervention
Not specified
Conditions
Stroke
Sponsor
The Affiliated People's Hospital of Fujian University of Traditional Chinese Medicine
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Prevention
Sex
All

Investigators

Sponsor
The Affiliated People's Hospital of Fujian University of Traditional Chinese Medicine

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients who meet the diagnostic criteria of stroke and are confirmed by CT or MRI;
  • 2\. Inpatients; 18 years old \<\= age \<\= 80 years old; first stroke; 1 \<\= course of disease \<\= 6 months; 2;
  • 3\. MMSE \> 24 in middle school and above, MMSE \> 20 in primary school, MMSE \> 17 in illiterate;
  • 4\. Patients with different degrees of limb motor dysfunction caused by stroke;
  • 5\. Patients with stable condition and conscious consciousness;
  • 6\. Patients without obvious communication barriers;
  • 7\. For patients who voluntarily sign the informed consent form, if the subjects are unable to sign, their immediate relatives or guardians will sign the informed consent on behalf of them.

Exclusion Criteria

  • 1\. Patients with other brain diseases, such as inflammation, infection, tumor and other brain damage sequelae;
  • 2\. Stroke patients without neurological deficit sequelae, such as transient ischemic attack (TIA), lacunar infarction, etc;
  • 3\. Patients with severe visual or hearing impairment, mental disorder and other factors that affect normal answering;
  • 4\. Patients with obvious mental retardation and dementia before onset;
  • 5\. Patients with severe heart, liver, kidney, endocrine and hematopoietic diseases;
  • 6\. Pregnant and lactating women;
  • 7\. Patients who are unwilling to cooperate or cannot tolerate the test;
  • 8\. Patients who are participating in other clinical trials affecting the evaluation of the results of this study.

Outcomes

Primary Outcomes

Not specified

Similar Trials